Navigation Links
Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
Date:12/6/2007

Company to Hold Conference Call on Monday, December 10, 2007

NEW HAVEN, Conn., Dec. 6 /PRNewswire-FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq: VION) today announced that preliminary data from its pivotal Phase II trial of Cloretazine(R) (VNP40101M) in elderly patients with de novo acute myelogenous leukemia (AML) would be presented in a poster at the 2007 American Society of Hematology Annual Meeting in Atlanta, Georgia on Saturday, December 8, 2007.

The poster presentation (#71-1) will be at the Georgia World Conference Center, Hall B4, from 9:00 a.m. to 7:30 p.m. Poster authors will be available from 5:30 p.m. to 7:30 p.m. at the poster. A copy of the poster will be available on Vion Pharmaceuticals' website, http://www.vionpharm.com, on Saturday, December 8, 2007 at 9:00 a.m. Eastern Time.

A press release related to the poster will be issued on Monday, December 10, 2007 at 7:30 a.m. Eastern Time. The Company also announced that it would hold a conference call to discuss the poster on Monday, December 10, 2007. The call will begin at 9:00 a.m. Eastern Time.

To participate in the conference call, please dial (866) 356-4123 in the U.S. ((617) 597-5393 for international callers) at least 15 minutes before the start of the call. When prompted for a pass code, please enter 16444471.

An audio webcast of the call will be accessible at http://www.vionpharm.com. Those who wish to listen to the conference call on the Web should visit the Investor Relations section of the Company's website at least 15 minutes prior to the event broadcast, and follow the instructions provided to a
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ON, Minn, Nov. 27 ACUO TECHNOLOGIE...nagement software, data migration tools and servic...Patent and Trademark Office has approved a patent ...hin a Computer Network." Acuo Technologies is plea...ellectual property. In general, the granted patent...
(Date:11/25/2009)...ON, Fla., Nov. 25 Amer... ("the Company") is pleased to announce that they ...nagement office in Shanghai, China. ,, ASR has ...n essential gateway for the development and produc...cts for children and adults to be distributed and ...
(Date:11/25/2009)...LADELPHIA, Nov. 25 ERT (...J. McKelvey, the Company,s President and CEO, and ...ent and CFO, are scheduled to present at the 21st ...0 PM EST on December 1, 2009 in New York City, New...sentation by visiting the Company,s corporate webs...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Cardio3 BioSciences Presents Update on C Cure 28R 29 Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress 13742 1Cardio3 BioSciences Presents Update on C Cure 28R 29 Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress 13742 2Cardio3 BioSciences Presents Update on C Cure 28R 29 Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress 13742 3Greenway Medical Technologies Closes 11th Consecutive Fiscal Year of Positive Growth 55744 1Greenway Medical Technologies Closes 11th Consecutive Fiscal Year of Positive Growth 55744 2Greenway Medical Technologies Closes 11th Consecutive Fiscal Year of Positive Growth 55744 3SCOLR Pharma Inc Appoints Stephen J Turner as CEO 55740 1SCOLR Pharma Inc Appoints Stephen J Turner as CEO 55740 2SCOLR Pharma Inc Appoints Stephen J Turner as CEO 55740 3
...LADELPHIA, July 3, 2007-- – The appearance o... (Tarceva) is,strongly associated with longer surv...;s developer, OSI Pharmaceuticals, Inc. This is,no...h a survival,advantage with EGFR inhibitors &ndash...imab, panitumumab and others designed to,block ove...
... CARLOS, Calif., July 5 /PRNewswire-FirstCall/ -- ...ata from the ANTHEM,(Anticoagulation with rNAPc2 T...ng at recombinant nematode anticoagulant protein c...es (ACS),preclinical data evaluating rNAPc2 in mo...ata evaluating the mechanism of NU172, a,short-act...
Other Medicine Technology:Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 2Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 3Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 4Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis 2Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis 3
(Date:11/27/2009)...tech firm Replikins Ltd. today issued its latest b.... It shows that the lethality of the virus has dr...irus,s current outbreak in the spring of 2009 to r...0.1). The H1N1 infectivity count, however, remains...EB) November 27, 2009 -- Biotech firm Replikins Lt...
(Date:11/27/2009).... 27 The Gymboree Corpor...t, CFO/COO, will present at the NASDAQ OMX 23rd In... Hotel in London, England, on Wednesday, December ...ive broadcast of The Gymboree Corporation,s presen...boree.com, click on "Our Company" at the bottom of...
(Date:11/27/2009)...NE, France, Nov. 27 Team Garmin-Sl...team dedicated to ethical sporting and developing ...d today that it will become Team Garmin-Transition...w sponsor of the team. Transitions Optical is the ...offering the most advanced photochromic technology...
(Date:11/27/2009)...aCare Holdings has announced that it has become a ...of the largest nonprofit organizations dedicated t... , Delray Beach, FL (Vocus...CBB: XCHO), a company specializing in the marketin...roducts, has announced today that is has become a ...
(Date:11/27/2009)...edented medical, economic burdens, study predicts ...The number of people with diabetes in the United S..., a new study predicts. , That would bring the ...e disease, up from 23.7 million today. , , At th...etes will triple, the study also warns, rising fro...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
...onsumption of a high fat diet has been found to su... that regulates insulin secretion (beta cells of t... secretion leads to diabetes. This molecula...e, there is insufficient insulin production, resul...
... study has been published by Alcoholism: Clinical ...raising the prices of alcoholic drinks does not re...towards drinkers going in for cheaper and inferior...ice posting' as an alternative policy measure. The...
...ichuan, China’s third most populated province is a...r agricultural centre and has more than 87 million... 70 people throughout Asia since 2003 and with 40 ... spread widely in the Dazhu County (south west Chi...
...he mysterious death of swallows in Malawi had rais...eak in South Africa. However, test reports // ha...f the dead swallows, much to relief of veterinary ...ere dying in large numbers. We don't know what kil...
...here is a dramatic shift in attitudes toward circu... // lowest rates of the practice and one of the h...ce widely viewed as unmanly, it is making a sudden...ng to the study published in the November 2005 iss...
...cottish Health Minister, Andy Kerr has urged to in...ry people as it could save lot of human loss dying...organ donors. Organ failure of heart and liver cau...ration with NHS organ donor register, which would ...
Other Medicine News:Health News:Price Of Alcohol Does Not Influence Consumption 2Health News:Men queue up for Circumcision In Swaziland To Prevent HIV/AIDS 2
Knolle-Shepard Lens Forceps
Buratto Insertion Forceps - Angled
Acrysof Insertion Forceps
Hydro Folding Forceps
Medicine Products: